Clinical Trial Update: A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing enzalutamide to bicalutamide in men with metastatic prostate cancer under castration levels; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-12-03